C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
11/1999
11/04/1999	WO1999032225A3 Catalytic composition based on chiral ligands with molybdenum, tungsten or chromium and method for asymmetric alkylation of allylic substrates
11/04/1999	CA2329821A1 Ccr-3 receptor antagonists
11/03/1999	EP0953624A1 Triarylamine compound and luminescent device
11/03/1999	EP0953567A2 Bicyclic substituted piperazine-, piperidine- and tetrahydropyridine derivatives, their preparation and their use as agents with central dopaminergic (dopamine D4 receptor) activity
11/03/1999	EP0953294A2 Use of 3,6-Dimethyl-2-(3H)-benzofuranone as a flavouring agent and new process for its preparation
11/03/1999	EP0952978A1 Metallocenes and catalysts for olefin-polymerisation
11/03/1999	EP0923544A4 Method for the synthesis of amines and amino acids with organoboron derivatives
11/03/1999	EP0784611B1 N-(ortho-substituted benzyloxy)imine derivatives and their use as fungicides, acaricides or insecticides
11/03/1999	CN1234020A Amide derivatives and their use as pesticides
11/03/1999	CN1233954A Taste-masked microcapsule compositions and method for mfg. same
11/03/1999	CN1046123C Process for producing alkoxyiminoacetamide compounds
11/02/1999	US5977371 Tandem asymmetric transformation process
11/02/1999	US5977367 N-aminoalkyldibenzofurancarboxamides; new dopamine receptor subtype specific ligands
11/02/1999	US5977187 4-substituted-1,2-naphthoquinones and their use in the inhibition of neoplastic cell growth
11/02/1999	US5977169 Substituted tetronic acids useful for treating HIV and other retroviruses
11/02/1999	US5977137 Sulfonamide inhibitors of aspartyl protease
11/02/1999	US5977112 Process of making substituted benzofurans
11/02/1999	US5977010 Containing nickel, manganese, zinc and cobalt oxide; calcium silicate and clay
11/02/1999	US5976397 Photofading inhibitor derivatives and their use in fabric treatment compositions
11/02/1999	CA2079486C Chelator compositions comprising alpha- diamine compounds
11/02/1999	CA2023311C Furan derivatives
10/1999
10/28/1999	WO1999054325A1 1-heteroindene derivatives and medicinal composition containing the same
10/28/1999	WO1999054324A1 Preparation of cis-6,6-dimethyl-3-oxa-bicyclo[3.1.0]hexan-2-one
10/28/1999	WO1999054323A1 Production of furanones
10/28/1999	WO1999054321A1 Substituted diamines and their use as cell adhesion inhibitors
10/28/1999	WO1999054290A1 Inhibitors of neuraminidases
10/28/1999	WO1999054284A1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase
10/28/1999	WO1999047497A3 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment
10/28/1999	WO1999024460B1 Dipeptide nitriles
10/28/1999	DE19909980A1 Verwendung von 3,6-Dimethyl-2-(3H)-bezofuranon als Aromastoff und ein neues Verfahren zu seiner Herstellung Use of 3,6-dimethyl-2- (3H) -bezofuranon as a flavoring agent and a novel method for its preparation
10/28/1999	DE19818732A1 New aryl substituted cyclic ketoenol compounds useful for control of insects and as herbicides
10/28/1999	DE19818340A1 Production of butan-1,4-diol, tetrahydrofuran and gamma-butyrolactone
10/28/1999	DE19818248A1 Production of highly pure butan-1,4-diol, useful for producing polyesters, gamma-butyrolactone and tetrahydrofuran
10/28/1999	DE19808261A1 Arylphenylsubstituierte cyclische Ketoenole Arylphenylsubstituierte cyclic ketoenols
10/28/1999	CA2329660A1 Inhibitors of neuraminidases
10/28/1999	CA2328413A1 Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase
10/28/1999	CA2328364A1 Production of furanones
10/28/1999	CA2319568A1 Preparation of cis-6,6-dimethyl-3-oxa-bicyclo¬3.1.0\|hexan-2-one
10/27/1999	EP0951466A2 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
10/27/1999	EP0951464A1 N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
10/27/1999	EP0951359A1 Process for the reactivation of iodine-containing catalysts
10/27/1999	CN1233237A Heteroaryl succinamides and their use as metalloproteinase inhibitors
10/27/1999	CN1233236A Halogenalkoximinoacetamide
10/27/1999	CN1232815A Process for preparation of cyclopropylacetylene derivatives
10/27/1999	CN1045959C Method for stage extraction of gibberellin A4 and A7 from gibberellin mixture
10/26/1999	US5973188 Anticoagulant; prevention cell, protein binding
10/26/1999	US5973168 Preparation process of phthalide compound
10/26/1999	US5973166 Subjecting n-maleimic acid in suitable reaction medium to aconditions sufficient to promote cyclodehydration using substituted amine or quaternaryammonium salt containing cation and anion as polarity modifier and an acid catalyst
10/26/1999	US5973113 Hypusine reagent for peptide synthesis
10/26/1999	US5972998 Treatment of autoimmune diseases such as rheumatoid arthritis, nephritis, uveitis, thyroiditis, and early stage of insulin dependent diabetes mellitus, systemic lupus erythematosus, psoriasis and inflammatory bowel disease
10/26/1999	US5972997 Antitumor agent for treating uterine and lung cancer
10/26/1999	US5972964 Aminomethylindans, -benzofurans and -benzothiophenes
10/26/1999	US5972957 Analgesics and antiarthritic agent
10/26/1999	US5972950 Antiinflammatory and analgesic agent
10/26/1999	US5972936 Benzofuran carboxamides and their therapeutic use
10/26/1999	US5972888 Lowering the production or release of neuropeptide y which comprises administering to a mammal in need thereof an effective amount of an isolated naturally occurring obesity protein, or a pharmaceutically acceptable salt thereof
10/26/1999	US5972878 A perfume oil for perfuming cosmetic compositions, cleaning compositions, detergent compositions, softener compositions, disinfectant compositions, textile treatment compositions and perfume compositions
10/26/1999	CA1340798C Disubstituted pyridines
10/21/1999	WO1999053039A1 Treatment of parasitic diseases by inhibition of cysteine proteases of the papain superfamily
10/21/1999	WO1999052910A1 Bicyclic hydroxamic acid derivatives
10/21/1999	WO1999052888A1 Butenolide derivatives as anti-cancer agents
10/21/1999	WO1999052879A1 Acylresorcinol derivatives as selective vitronectin receptor inhibitors
10/21/1999	WO1999052874A1 Difluoroalkene derivatives, process for producing the same, and agricultural or horticultural pest control agent
10/21/1999	WO1999043643A3 Metal-catalyzed arylations and vinylations of hydrazines, hydrazones, hydroxylamines and oximes
10/21/1999	WO1999039712A9 Substituted semicarbazides and the use thereof
10/21/1999	DE19909761A1 New optically inactive benzo(b)furan, benzo(1,2-b:4,5-b')difuran and benzo(1,2-b:5,4-b')difuran derivatives, used in liquid crystal media
10/21/1999	DE19909760A1 New benzo(b)furan derivatives used as components of liquid crystal media for liquid crystal and electro-optical displays
10/21/1999	CA2327282A1 Treatment of parasitic diseases by inhibition of cysteine proteases of the papain superfamily
10/20/1999	EP0950405A1 Remedies for renal diseases and organ-preserving agents
10/20/1999	EP0950059A1 Cyclic sulfone derivatives
10/20/1999	EP0949919A1 A process for stabilizing levogyre ascorbic acid (laa) and stable laa compositions
10/20/1999	EP0815097B1 Method of producing 1,4-butanediol and tetrahydrofuran from furan
10/20/1999	EP0788476B1 Stilbene derivatives useful as cyclooxygenase-2 inhibitors
10/20/1999	EP0708651B1 Therapeutic agent
10/20/1999	CN1232460A Process for preparing phthalides
10/20/1999	CN1232450A 2- and 2,5-substd. phenylketoenols
10/20/1999	CN1232443A Novel p-terphenyl compounds
10/20/1999	CN1232392A Pharmaceutical compositions comprising tyrphostins
10/19/1999	US5969164 Catalysts for the hydrogenation of maleic acid to 1,4-butanediol
10/19/1999	US5969163 Contacting solution of lawsone in dimethyl sulfoxide at low temperature with lithium hydride and warming to form lithium salt, alkylating with allyl halide in presence of lithium iodide, cyclizing alkylated lawsone derivatives
10/19/1999	US5969162 Process for purifying phthalide
10/19/1999	US5969158 Administering derivatives of homoserine lactone to inhibit histamine release from mast cells and/or basophils
10/19/1999	US5969133 Bioreductive cytotoxic agents
10/19/1999	US5968985 Benzoylguanidine derivatives as medicaments
10/19/1999	US5968977 Ketonitrile derivatives and antibacterial agent and drugs containing the same
10/19/1999	US5968970 Treatment of hiv
10/19/1999	US5968942 Inhibitors of hiv protease
10/19/1999	US5968935 Agent for potentiating nerve growth factor activity containing 1,2-ethanediol derivative or salt thereof
10/19/1999	US5968908 Restricted 9-cis retinoids
10/19/1999	US5968697 Unsaturated furan and/or thiophene derivatives substituted with cyano and/or ester groups; charge transport and charge generating compounds
10/19/1999	US5968484 Applying 2-organocarbonylacrylonitrile derivative as sunscreen agent
10/14/1999	WO1999051585A1 Composition for the treatment of cancer and colitis ulcerosa as well as the use of a titanium complex and a zinc salt for the preparation of the composition
10/14/1999	WO1999051241A1 Calcilytic compounds and method of use
10/14/1999	DE19815639A1 Verfahren zur Herstellung von Zuckeralkoholen Process for the preparation of sugar alcohols
10/14/1999	CA2327188A1 Calcilytic compounds and method of use
10/13/1999	EP0949254A1 Process for producing cyclic ethers by liquid phase reaction
10/13/1999	EP0949233A2 Process for the preparation of sugar alcohols
10/13/1999	EP0948493A1 Indene inhibitors of cox-2
10/13/1999	EP0948492A1 Process for the preparation of heteroaryl-phenylalanines
10/13/1999	EP0948327A1 Antidiabetic agents

1 ... 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 ... 472